Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
A summary of what we know
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm
...
ents (e.g., interpersonal psychotherapy or cognitive behavioural therapy, including behavioural activation) or antidepressant medication (e.g., SSRIsi and tricyclic antidepressants) be considered in adults with moderate-severe depression. Health care workers need to know whether these treatments have different effects, including side-effects, in treating depressive disorder in the short and long term, in order to improve clinical decision-making.
more
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
Médicaments et dispositifs médicaux pour une population de
10 000 personnes pendant environ 3 mois
PLoS Medicine Vol. 6 no. 10 (2009) e1000165
Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the
...
patient, health-care provider, and health system level prevent the implementation of optimal primary and secondary prevention. Identification of the particular barriers that exist in resource-constrained settings is necessary to inform effective strategies to reduce the identified evidence-practice gaps. Furthermore, targeting modifiable factors that contribute most significantly to the global burden of CVD, including tobacco use, hypertension, and secondary prevention for CVD will lead to the biggest gains in mortality reduction. We review a select number of novel, resource-efficient strategies to reduce premature mortality from CVD, including: (1) effective measures for tobacco control; (2) implementation of simplified screening and management algorithms for those with or at risk of CVD, (3) increasing the availability and affordability of simplified and cost-effective treatment regimens including combination CVD preventive drug therapy, and (4) simplified delivery of health care through task-sharing (non-physician health workers) and optimizing self-management (treatment supporters). Developing and deploying systems of care that address barriers related to the above, will lead to substantial reductions in CVD and related mortality.
more
Il est prouvé que l’activité physique régulière aide à prévenir et à traiter les maladies non transmissibles (MNT), telles que les cardiopathies,
les accidents vasculaires cérébraux, le diabète, ainsi que les cancers du sein et du côlon. Elle aide également à prévenir l’hypertensi
...
on, la surcharge pondérale et l’obésité, et peut améliorer la santé mentale, la qualité de vie et le bien-être.
more
Respecter les regles d'hygiène est crucial aussi bien pour la santé des patients que vous recevez que pour votre propre sécurité. On oublie souvent que la prévention des maladies infectieuses grace a l'hygiène sauve davantage de vie chaque ann
...
ée que tous les rapports de
more
Q8.SCOPING QUESTION: In adults and older adolescents with depressive disorder, what is the comparative effectiveness of different formats of psychological treatments?
These guidelines deal specifically with water, sanitation and hygiene, and are designed to be used in schools in low-cost settings in low- and medium-resource countries to:
• assess prevailing situations and plan for required improvements;
• develop and reach essential safety standards as a f
...
irst goal; and
• support the development and application of national policies.
more